Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor tyrosine-protein kinase erbB-4 (ERBB4/HER4) is a transmembrane receptor tyrosine kinase that belongs to the epidermal growth factor receptor (EGFR/ErbB/HER) family. Upon ligand binding, it dimerizes and activates downstream signaling pathways like PI3K-AKT and Ras-MAPK, influencing various cellular processes. It plays crucial roles in heart development, the central nervous system, and mammary gland function. Aberrant ERBB4 signaling is implicated in cancer and neurological disorders.
Tyrosine kinase inhibition (for potential therapeutics)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor tyrosine-protein kinase erbB-4 (ERBB4).